Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro altogether.
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology Read More »
Vas Narasimhan said on Tuesday that if the U.S. adopts international drug pricing, all companies would have to “relook at their medium- to long-term outlook.”
Novartis CEO Brushes Off Tariffs but Says Trump Pricing Controls Would Be ‘Devastating’ Read More »
The company’s $3 billion in earnings for the first quarter missed on both top and bottom line, according to BMO Capital Markets. Adding insult to injury, the FDA declined to approve a prefilled syringe of its ophthalmology cornerstone.
Regeneron Shares Tumble as Eylea Declines Make for a ‘Messy Quarter’ to Come Read More »
Biohaven will use the money to bankroll commercial preparations for the spinocerebellar ataxia drug candidate troriluzole, which is currently under FDA review with a decision expected in the third quarter.
Biohaven Grabs a Foothold With $600M Windfall From Oberland Capital Read More »
While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by various regulatory roadblocks.
In another lawsuit against the HHS over the grant cuts, municipalities in Texas, Tennessee, Ohio and Missouri, as well as a labor union, argue eliminating the funding would weaken their ability to respond to infectious disease outbreaks, like measles.
HHS sued again over cuts to public health grants Read More »
Pfizer’s R&D organization has been in flux for almost two years now, since the $43 billion acquisition of ADC specialist Seagen. The new cuts were revealed in the company’s Q1 earnings report.
Pfizer Announces Another $1.7B in Cost Savings, Including R&D Revamp Read More »
Por causas que en el momento de escribir estas líneas aún se desconocen, el 28 de abril de 2025, poco después de las 12:30, se desencadenó en la península Ibérica y otros puntos del sur de Europa un apagón eléctrico general, que duró muc …
Un colosal apagón eléctrico que pasará a la historia Read More »
La evolución ha llegado a los sistemas de climatización de nuestras casas, y el presente y el futuro de la energía tiene nombre. Se trata de una tecnología llamada aerotermia, que es un sistema de climatización que usa el aire del exterior para aumentar o …
En la dieta moderna, el consumo excesivo de sal —principalmente cloruro de sodio— es uno de los factores dietéticos más asociados con el desarrollo de enfermedades crónicas. Un aporte superior a los 5 g diarios de sal (2 g de sodio) incrementa significativamente el r …
¿Por qué no es conveniente consumir demasiada sal en la dieta? Read More »
